TC Biopharm Holdings PLC
13F holders, Q1 2025 (March 31)1holders −11
0new positions
11sold out
$0.20avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding TC Biopharm Holdings PLC in their 13F filings, down 11 from Q4 2024. 0 opened new positions and 11 sold out. The largest holder was Rhumbline Advisers ($34).
- Company
- TC Biopharm Holdings PLC
- CUSIP
- 87807D509
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 11 | $34K |
All 13F filers, Q4 2024 → Q1 2025: 54,657 shares sold, net −54,657 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Rhumbline Advisers | 0.00% | Reduce -84.0% | 173 | $34 |
"% of holder's portfolio" is TC BIOPHARM HOLDINGS PLC's weight in each manager's 13F, not the share of TC Biopharm Holdings PLC the manager owns.